Indeed, overexpressed LRG1 was found in obese humans and mice, where it promoted hepatic steatosis, enhancing lipogenesis and suppressing fatty acid β-oxidation, and inhibited IRS1 and IRS2, thus promoting IR and prediabetes [69]. Here, LRG1 is linked to prediabetes syndrome.